Young Researchers’ Roundtable Breakfast

Young Researchers’ Roundtable Breakfast
Metastatic Breast Cancer: Filling the Gap

Thursday, November 9, 2017
The William & Ida Friday Center
8:30 AM – 11:00 AM

Susan G. Komen North Carolina Triangle to the Coast’s Roundtable Breakfast is a unique opportunity to connect early-career breast cancer researchers with established local Komen Scholars, physicians, scientists, breast cancer survivors, and metavivors in a meaningful way. During this morning event, young researchers will hone their communication skills and articulate their research findings to an audience well-versed in breast cancer treatment and therapies. 

The focus of this year’s breakfast will be Metastatic Breast Cancer: Filling the Gap. The program will consist of four brief presentations followed by a short panel moderated by Dr. Lisa Carey, a well-known Komen Scholar from UNC. Following the panel, there will be breakout group discussion about breast cancer research and its impact on patient care. Our goal is to move closer to finding the cures to breast cancer by encouraging open dialogue.

To RSVP for the Young Researchers’ Roundtable Breakfast please click the link below



Thank you to our Breakfast Sponsors


Presenting Sponsor

Bronze Research Series Sponsors

Coastal Federal Credit Union

Cohera Medical, Inc.



Young Researchers’ Roundtable Breakfast Speakers


Dr. Lisa Carey
Komen Scholar

Dr. Carey is an experienced clinical/translational researcher and serve as UNC Lineberger Comprehensive Cancer Center Associate Director for Clinical Sciences. She developed and has been the PI for multiple clinical and translational trials, and has a particular interest in the clinical implications of different molecular subtypes of breast cancer. These include a seminal JAMA article that examined racial disparities among breast cancer molecular subtypes, and the Clinical Cancer Research article that first explained the paradox of high chemosensitivity, but poor outcomes among certain types of breast cancer, and CALGB 40601, a randomized phase III trial of dual versus single HER2-directed therapy with mandatory research biopsies to identify predictive biomarkers. Dr. Carey is a member of the NCI CTAC’s Breast Cancer Steering Committee. She was awarded the Doris Duke Clinician Scientist Award in 1999, a Career Development Award from the NCI in 2000 and was inducted into the Johns Hopkins Society of Scholars in 2008. In 2011, Dr. Carey was honored with the NCI Director’s Service Award and became the Breast Committee co-chair of the Alliance for Clinical Trials in Oncology in 2016. 

Patty Spears

Komen Advocate in Science

Patty is an 18-year breast cancer survivor and cancer research advocate. She is a Komen Scholar and is currently the Vice Chair of the Komen Advocates in Science Steering Committee.  She has extensive clinical trial advocacy experience and has previously served as an advocate on the Translational Breast Cancer Research Consortium (TBCRC) and NCI Breast Cancer Steering Committee (BCSC).  She is currently the Co-Chair of the Patient Advocate Committee of the Alliance for Clinical Trials in Oncology.  Patty also has an interest in Patient Reported Outcomes (PROs) in drug development.  Patty is currently working as a scientific research manager and patient advocate at UNC Lineberger Comprehensive Cancer Center. 


Katrina Cooke

Living with Metastatic Breast Cancer

Katrina Cooke is a single mom of 2 amazing boys. She has been battling Stage IV, Metastatic Breast Cancer since the very young age of 36 years old. She has dedicated her life to helping others with this dreaded disease as often and as much as she can. This includes emotional support and helping to advocate for the friends she’s lost, the friends she fights with and herself. Metastatic Breast Cancer research is what will keep her here on this earth to serve another day


Dr. Lynn McRoy
Sr. Director of Pfizer Innovative Health

Lynn McRoy, MD is a Fellow of the American College of Surgeons and an experienced breast surgeon who practiced for 16 years before transitioning to industry. Lynn is the team lead for the breast cancer platform in US Medical Affairs for Pfizer Oncology. She has held a variety of roles in medical affairs, drug safety, and medical device development while working in the industry for the past 10 years.  She has extensive experience in observational study design, patient-centered outcome research, and patient engagement.


Go to Top